Dolasetron
Alternative Names: Anemet; Anzemet; MDL 73147EFLatest Information Update: 25 Sep 2021
At a glance
- Originator sanofi-aventis
- Developer Sanofi; sanofi-aventis
- Class Antiemetics; Antipsychotics; Indoles; Quinolizines; Small molecules
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Nausea and vomiting
- Discontinued Psychotic disorders